TY - JOUR
T1 - Optimal sampling in derivation studies was associated with improved discrimination in external validation for heart failure prognostic models
AU - the investigators for the WET-NaDEF Collaboration Project
AU - Iwakami, Naotsugu
AU - Nagai, Toshiyuki
AU - Furukawa, Toshiaki A.
AU - Tajika, Aran
AU - Onishi, Akira
AU - Nishimura, Kunihiro
AU - Ogata, Soshiro
AU - Nakai, Michikazu
AU - Takegami, Misa
AU - Nakano, Hiroki
AU - Kawasaki, Yohei
AU - Alba, Ana Carolina
AU - Guyatt, Gordon Henry
AU - Shiraishi, Yasuyuki
AU - Kohsaka, Shun
AU - Kohno, Takashi
AU - Goda, Ayumi
AU - Mizuno, Atsushi
AU - Yoshikawa, Tsutomu
AU - Anzai, Toshihisa
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/5
Y1 - 2020/5
N2 - Objectives: The objective of the study was to identify determinants of external validity of prognostic models. Study Design and Setting: We systematically searched for studies reporting prognostic models of heart failure (HF) and examined their performance for predicting 30-day death in a cohort of consecutive 3,452 acute HF patients. We applied published critical appraisal tools and examined whether bias or other characteristics of original derivation studies determined model performance. Results: We identified 224 models from 6,354 eligible studies. The mean c-statistic in the cohort was 0.64 (standard deviation, 0.07). In univariable analyses, only optimal sampling assessed by an adequate and valid description of the sampling frame and recruitment details to collect the population of interest (total score range: 0–2, higher scores indicating lower risk of bias) was associated with high performance (standardized β = 0.25, 95% CI: 0.12 to 0.38, P < 0.001). It was still significant after adjustment for relevant study characteristics, such as data source, scale of study, stage of illness, and study year (standardized β = 0.24, 95% CI: 0.07 to 0.40, P = 0.01). Conclusion: Optimal sampling representing the gap between the population of interest and the studied population in derivation studies was a key determinant of external validity of HF prognostic models.
AB - Objectives: The objective of the study was to identify determinants of external validity of prognostic models. Study Design and Setting: We systematically searched for studies reporting prognostic models of heart failure (HF) and examined their performance for predicting 30-day death in a cohort of consecutive 3,452 acute HF patients. We applied published critical appraisal tools and examined whether bias or other characteristics of original derivation studies determined model performance. Results: We identified 224 models from 6,354 eligible studies. The mean c-statistic in the cohort was 0.64 (standard deviation, 0.07). In univariable analyses, only optimal sampling assessed by an adequate and valid description of the sampling frame and recruitment details to collect the population of interest (total score range: 0–2, higher scores indicating lower risk of bias) was associated with high performance (standardized β = 0.25, 95% CI: 0.12 to 0.38, P < 0.001). It was still significant after adjustment for relevant study characteristics, such as data source, scale of study, stage of illness, and study year (standardized β = 0.24, 95% CI: 0.07 to 0.40, P = 0.01). Conclusion: Optimal sampling representing the gap between the population of interest and the studied population in derivation studies was a key determinant of external validity of HF prognostic models.
KW - External validation
KW - Heart failure
KW - Mortality
KW - Prediction
KW - Prognosis
KW - Prognostic model
KW - Study bias
KW - Systematic review
UR - http://www.scopus.com/inward/record.url?scp=85079898921&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079898921&partnerID=8YFLogxK
U2 - 10.1016/j.jclinepi.2020.01.011
DO - 10.1016/j.jclinepi.2020.01.011
M3 - Article
C2 - 32004670
AN - SCOPUS:85079898921
SN - 0895-4356
VL - 121
SP - 71
EP - 80
JO - Journal of Clinical Epidemiology
JF - Journal of Clinical Epidemiology
ER -